この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1997/9/231 分で読めます
Revised Precautionary Measures to Reduce the Possible Transmission of Creutzfeldt-Jakob Disease (CJD) by Blood and Blood Products; Guidance Document; Availability
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing the availability of a guidance document entitled ``Revised Precautionary Measures to Reduce the Possible Transmission of Creutzfeldt-Jakob Disease (CJD) by Blood and Blood Products,'' dated December 11, 1996. The guidance document is intended to provide recommendations to the blood industry and may include information useful to other interested persons.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →